Home Page
|
Company
Company Profile
Management
Board of Directors
Scientific Advisory Board
Contact Us
|
Technology
Background
The Cell Enrichment Process
Intellectual Property
|
Applications
CEP Separation System
Prenatal Testing
Stem Cells
Cancer Metastasis
|
Investor Relations
Investment Opportunity
Strategic Partnerships
|
FAQS
|
Home Page
The CEP Advantage
News and Media
Site Map
Contact Us
News
BioCep closes 2 million NIS round
BioCep chosen to present at the 2010 Bio Incubator conference
Professor Dian Donnai joins BioCep's scientific advisory board
BioCep appoints Doron Birger, former CEO at Elron as the Chairman of its board
BioCep receives OCS grant for 2009
CEP has been validated by a leading lab and found to be significantly more effective than current separation solutions.
BioCep begins two beta sites in leading research labs in Israel.
Site Search
Search
News
>> CEP has been validated by a leading lab and found to be significantly more effective than current separation solutions.
CEP has been validated by a leading lab and found to be significantly more effective than current separation solutions.
CEP has been validated by a leading lab and found to be significantly more effective than current separation solutions.
LiveCity - Website Builder
